Treating Depression with Ketamine and Psilocybin

Posted: by UAR News on 17/12/25

More on these Topics:

Treating Depression with Ketamine and Psilocybin

In the second of a two-part series, filmed by the UAR team, we investigate the research carried out by Professor Emma Robinson at the University of Bristol. 

We learn how Emma and her team are studying the effects of Ketamine and Psilocybin when treating mental health disorders, most notably depression and anxiety.  

In groundbreaking research, her team have been analysing how both drugs impact memory and decision making in the brain.  In the film, we discover how Ketamine and 

Psilocybin effect the brain of rodents, and a simple yet powerful test for affective bias - a key tool in determining the drugs’ efficacy in treating mental health disorders.

For more information on the Professor Emma Robinson and her research, see: https://www.bristol.ac.uk/people/person/Emma-Robinson-19982d31-4c91-49a9-b797-80e967806092/

More on these Topics:

Last edited: 17 December 2025 11:44

Back to News

Get the latest articles and news from Understanding Animal Research in your email inbox every month.
For more information, please see our privacy policy.